Publications
- Phosphatidylserine-dependent anti-prothrombin antibodies (aPS/PT) in infliximab-treated patients with inflammatory bowel diseases2013 | First Faculty of Medicine
- Influence of albuminemia on the pharmacokinetics of infliximab in patients with inflammatory bowel diseases2011 | First Faculty of Medicine
- Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases2011 | First Faculty of Medicine
- Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort2010 | First Faculty of Medicine
- Clinical significance of anti-glycan antibodies in patients with Crohn's disease2008 | First Faculty of Medicine
- Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's diseasePublication without faculty affiliation
- Outcomes of Treatment With Infliximab for Ulcerative Colitis and Predictors of Sustained Clinical ResponsePublication without faculty affiliation
- Outcomes of Treatment With Infliximab for Ulcerative Colitis and Predictors of Sustained Clinical Response.Publication without faculty affiliation
- A switch from originator-adalimumab to the biosimilar SB5 in patients with Crohn's disease: an analysis of two propensity score-matched cohorts2022 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Telemedicine and inflammatory bowel disease - results of the IBD Assistant pilot project2020 | Faculty of Physical Education and Sport, First Faculty of Medicine
Loading network view...